Original Papers - Incontinence & Urodynamics

Biocompatibility and tissue integration of autologous fat grafts and synthetic implants following submucosal implantation into the urinary bladder

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 24 December 2025
402
Views
160
Downloads

Authors

Background: In urological practice, the search continues for volume-forming materials with optimal biocompatibility, a prolonged therapeutic effect, and a minimal risk of complications. This issue is particularly critical in reconstructive and functional urology, where longterm stability of the outcome is required without inducing damage to the surrounding tissues. Existing synthetic and biological fillers present several limitations, including a tendency toward resorption, fibrosis, shape instability, and the risk of immune reactions. Although the efficacy of certain materials has been demonstrated, issues related to their long-term biocompatibility and morpho-functional stability remain unresolved.
Methods: Ninety-six sexually mature male Belgian rabbits were used in the experiment. Under intravenous anesthesia, a submucosal injection of the volume-forming material (0.3 mL) was administered into the wall of the urinary bladder. Four types of materials were employed in the study: autologous fat graft, autologous fat graft combined with platelet-rich plasma (PRP), poly-L-lactic acid (aesPLLa), and macroparticles of a polyacrylate-polyvinyl alcohol copolymer. Animals were divided into four experimental groups according to the type of material administered. To assess tissue responses and graft characteristics, subgroups of eight animals from each experimental group were euthanized on days 14, 30, and 90 post-intervention for comprehensive morphological evaluation, including histological, histochemical, histomorphometric, and morphometric analyses. The primary evaluation parameters included the intensity of the inflammatory response, the degree of vascularization, the nature of cellular infiltration, the extent of fibrotic changes, and the preservation of the implanted material.
Results: The study demonstrated that the combination of an autologous fat graft with platelet-rich plasma (PRP) promoted more intensive microvascular network formation, reduced inflammatory infiltration, and ensured a more uniform distribution of the transplanted tissue compared with the other experimental groups. The obtained data indicate the high biocompatibility of this combination and its potential effectiveness as an alternative to synthetic volume-forming materials, particularly in clinical settings requiring a prolonged volumetric effect with minimal risk of complications.
Conclusions: The combination of platelet-rich plasma (PRP) with an autologous fat graft, as well as the use of the synthetic material polyacrylate and polyvinyl alcohol copolymer, appear to be the most promising approaches for achieving a stable and biocompatible volume-forming effect in the correction of lower urinary tract pathologies. At the same time, despite the confirmed high biocompatibility of the investigated substrates in the short term, questions regarding their long-term safety remain unresolved, including the risk of fibrotic changes and potential functional impairments of the urinary bladder. These aspects warrant further investigation and clinical validation.

Downloads

Download data is not yet available.

Citations

1. Serati M, Braga A, Vitelli A, et al. Urethral bulking agents for the treatment of recurrent stress urinary incontinence: A systematic review and meta-analysis. Int Urogynecol J. 2022; 33:1137-1146.
2. Oguz F, Yildiz T, Gecit I, et al. The outcomes of two different bulking agents (dextranomer hyaluronic acid copolymer and polyacrylate polyalcohol copolymer) in the treatment of primary vesicoureteral reflux. Int Braz J Urol. 2016; 42:514-520.
3. Bozacı AC, Aki FT, Zeybek D, et al. Comparison of the histological response to different bulking materials used in endoscopic vesicoureteral reflux surgery. Bagcilar Med Bull. 2022; 9:117-123.
4. Sharifiaghdas F, Narouie B, Soltani MH, et al. Investigating the clinical outcomes of bulking agent injection in comparison with modified Gil Vernet anti-vesicoureteral reflux surgery in children with high-grade reflux (4 or 5). Afr J Urol. 2023; 29:67.
5. Vasudeva P, Yadav S, Sinha S, et al. Autologous versus synthetic midurethral transobturator sling: A systematic review and metaanalysis of outcomes. Neurourol Urodyn. 2024; 43:2017-2029.
6. Kuismanen K, Kaestel M, Seiler R, et al. Autologous adipose stem cells in treatment of female stress urinary incontinence: Results of a pilot study. Stem Cells Transl Med. 2014; 3:315-321.
7. Daneshpajooh A, Farsinejad A, Derakhshani A, et al. Comparing periurethral injection of autologous muscle-derived stem cells and fibroblasts with midurethral sling surgery in the treatment of female stress urinary incontinence: A randomized clinical trial. J Stem Cells Regen Med. 2022; 18:43-51.
8. Legonkova OA, Sultanova NO, Stafford VV, et al. Long-term biodegradation of polyacrylamide gel residues in mammary glands: Physicochemical analysis, chromatographic detection, and implications for chronic inflammation. Molecules. 2024; 29:3247.
9. Carey JM, Chon JK, Leach GE. Urethrolysis with Martius labial fat pad graft for iatrogenic bladder outlet obstruction. Urology. 2003;61:21-25.
10. Inoyatov JS, Snurnitsyna OV, Lobanov MV, et al. Minimally invasive combined surgical treatment of postcoital cystitis. Andrology and Genital Surgery. 2020; 21:20-25.
11. Alshuaibi M, Zugail AS, Lombion S, Beley S. New protocol in the treatment of Peyronie's disease by combining platelet-rich plasma, percutaneous needle tunneling, and penile modeling: Preliminary results. Fr J Urol. 2024; 34:102526.
12. Cirigliano L, Di Giovanni A, Giordano A, et al. Hyaluronic acid injection for the management of Peyronie’s disease. J Sex Med. 2022;19: S16.
13. Casavantes L, Lemperle G, Morales P. Penile girth enhancement with polymethylmethacrylate-based soft tissue fillers. Aesthet Surg J. 2016; 36:1414-1422.
14. Ministry of Health of the Republic of Kazakhstan. Order No. KR DSM-248/2020 dated December 11, 2020. On approval of the rules for conducting clinical trials of medicinal products and medicaldevices. Accessed: 2022 Apr 2. Available from: https://adilet.zan.kz/rus/docs/V2000021772/info
15. Ministry of Health and Social Development of the Republic of Kazakhstan. Good Laboratory Practice (GLP) Standard. Order No. 392 dated May 27, 2015. Accessed: 2022 Apr 19. Available from: https://adilet.zan.kz/rus/docs/V1500011506
16. European Commission. European Convention for the protection of vertebrate animals used for experimental and other scientific purposes. Accessed: 2023 Feb 2. Available from: https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX:21999A0824(01)
17. Allgoewer A, Mayer B. Sample size estimation for pilot animal experiments by using a Markov Chain Monte Carlo approach. Altern Lab Anim. 2017; 45:83-90.
18. Hersant B, Bouhassira J, SidAhmed-Mezi M, et al. Should platelet-rich plasma be activated in fat grafts? An animal study. J Plast Reconstr Aesthet Surg. 2018; 71:681-690.
19. Dupras J, Vachon P, Cuvelliez S, Blais D. Anesthesia of the New Zealand rabbit using the combination of tiletamine-zolazepam and ketamine-midazolam with or without xylazine. Can Vet J. 2001;42:455-460.
20. Pak I, Askarov M, Kissamedenov N, Klyuyev D, Kamyshanskiy Y. Experimental study on clinical and morphological determination of the optimal cannula diameter for lipoaspirate harvest from rabbit inguinal fat pad. J Appl Biomed. 2023; 21:99-105.
21. International Organization for Standardization. Biological evaluation of medical devices - Part 6: Tests for local effects after implantation. ISO/DIS 10993-6:2024.
22. Liao HT, Marra KG, Rubin JP. Application of platelet-rich plasma and platelet-rich fibrin in fat grafting: Basic science and literature review. Tissue Eng Part B Rev. 2014; 20:267-276.
23. Xiong BJ, Tan QW, Chen YJ, et al. The effects of platelet-rich plasma and adipose-derived stem cells on neovascularization and fat graft survival. Aesthet Plast Surg. 2018; 42:1-8.
24. El-Sharkawy H, Kantarci A, Deady J, et al. Platelet-rich plasma: Growth factors and pro- and anti-inflammatory properties. J Periodontol. 2007; 78:661-669.

How to Cite



Biocompatibility and tissue integration of autologous fat grafts and synthetic implants following submucosal implantation into the urinary bladder. (2025). Archivio Italiano Di Urologia E Andrologia, 97(4). https://doi.org/10.4081/aiua.2025.14657